Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Vitamin D Testing Sales Market by Vitamin Type (Vitamin D2, Vitamin D3), by Application (Functional Food Beverages, Pharmaceuticals, Animal Feed Pet Food, Personal Care) and by End User (Pediatrics, Adults, Geriatrics, Pregnant Women): Global Opportunity Analysis and Industry Forecast, 2023-2032

A02629

Pages: NA

Charts: NA

Tables: NA

Vitamin D plays a vital role to control the calcium and phosphate levels in the body. It also helps maintain the cell cycle, fetus development, prevention of neuromuscular disorders, and bone disorders. The deficiency of vitamin D leads to rickets, osteoporosis, cardiovascular diseases, cognitive disorders, cancer, autoimmune diseases, and asthma.

Increase in prevalence of vitamin D deficiency due to the lack of exposure to sunlight, low intake of vitamin D diet, poor absorption of food, liver or kidney diseases, and certain drugs such as phenytoin, rifampin, and phenobarbital majorly drives the market growth. In addition, rise in the prevalence of orthopedic diseases, cognitive disorders, cancer, and asthma fuels the growth of the market.

Furthermore, increase in investment and awareness by government and private organizations and cost-efficient vitamin D deficiency test is anticipated to create new opportunities during the forecast period. However, decline rate of reimbursement and stringent government regulations associated with the sales of vitamin D deficiency is anticipated to hinder the growth of the market.

The market is segmented on the basis of vitamin type, application, end user, and geography. Based on the vitamin type, it is bifurcated into vitamin D3 and D2. Based on the application, it is classified into functional food & beverages, pharmaceuticals, animal feed & pet food, and personal care.

Based on end users, the vitamin D testing market is divided into pediatrics, adults, geriatrics, and pregnant women. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the global vitamin D testing sales market, with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments facilitates to understand various products of the market.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

 Key Market Segments

  • By Vitamin Type
    • Vitamin D2
    • Vitamin D3
  • By Application
    • Functional Food & Beverages
    • Pharmaceuticals
    • Animal Feed & Pet Food
    • Personal Care
  • By End User
    • Pediatrics
    • Adults
    • Geriatrics
    • Pregnant Women
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Abbott Laboratories Inc.
  • Tosoh Bioscience
  • Siemens Healthineers
  • Biokit S.A.
  • Hologic, Inc.
  • The Vitamin D Company
  • F. Hoffmann-La Roche
  • DiaSorin S.p.A.
  • BioMrieux Inc
  • QUALIGEN

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: VITAMIN D TESTING SALES MARKET, BY VITAMIN TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Vitamin Type

    • 4.2. Vitamin D2

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Vitamin D3

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: VITAMIN D TESTING SALES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Functional Food And Beverages

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Pharmaceuticals

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Animal Feed And Pet Food

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Personal Care

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: VITAMIN D TESTING SALES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Pediatrics

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Adults

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Geriatrics

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Pregnant Women

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: VITAMIN D TESTING SALES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Vitamin Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Vitamin D Testing Sales Market

        • 7.2.6.1. Market Size and Forecast, By Vitamin Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Vitamin D Testing Sales Market

        • 7.2.7.1. Market Size and Forecast, By Vitamin Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Vitamin D Testing Sales Market

        • 7.2.8.1. Market Size and Forecast, By Vitamin Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Vitamin Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Vitamin D Testing Sales Market

        • 7.3.6.1. Market Size and Forecast, By Vitamin Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Vitamin D Testing Sales Market

        • 7.3.7.1. Market Size and Forecast, By Vitamin Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Vitamin D Testing Sales Market

        • 7.3.8.1. Market Size and Forecast, By Vitamin Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Vitamin D Testing Sales Market

        • 7.3.9.1. Market Size and Forecast, By Vitamin Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Vitamin D Testing Sales Market

        • 7.3.10.1. Market Size and Forecast, By Vitamin Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Vitamin D Testing Sales Market

        • 7.3.11.1. Market Size and Forecast, By Vitamin Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Vitamin D Testing Sales Market

        • 7.3.12.1. Market Size and Forecast, By Vitamin Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Vitamin Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Vitamin D Testing Sales Market

        • 7.4.6.1. Market Size and Forecast, By Vitamin Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Vitamin D Testing Sales Market

        • 7.4.7.1. Market Size and Forecast, By Vitamin Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Vitamin D Testing Sales Market

        • 7.4.8.1. Market Size and Forecast, By Vitamin Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Vitamin D Testing Sales Market

        • 7.4.9.1. Market Size and Forecast, By Vitamin Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Vitamin D Testing Sales Market

        • 7.4.10.1. Market Size and Forecast, By Vitamin Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Vitamin D Testing Sales Market

        • 7.4.11.1. Market Size and Forecast, By Vitamin Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Vitamin D Testing Sales Market

        • 7.4.12.1. Market Size and Forecast, By Vitamin Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Vitamin D Testing Sales Market

        • 7.4.13.1. Market Size and Forecast, By Vitamin Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Vitamin D Testing Sales Market

        • 7.4.14.1. Market Size and Forecast, By Vitamin Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Vitamin Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Vitamin D Testing Sales Market

        • 7.5.6.1. Market Size and Forecast, By Vitamin Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Vitamin D Testing Sales Market

        • 7.5.7.1. Market Size and Forecast, By Vitamin Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Vitamin D Testing Sales Market

        • 7.5.8.1. Market Size and Forecast, By Vitamin Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Vitamin D Testing Sales Market

        • 7.5.9.1. Market Size and Forecast, By Vitamin Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Vitamin D Testing Sales Market

        • 7.5.10.1. Market Size and Forecast, By Vitamin Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Vitamin D Testing Sales Market

        • 7.5.11.1. Market Size and Forecast, By Vitamin Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. BioMrieux Inc

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Abbott Laboratories Inc.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Siemens Healthineers

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. F. Hoffmann-La Roche

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. DiaSorin S.p.A.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Hologic, Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Biokit S.A.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. The Vitamin D Company

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Tosoh Bioscience

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. QUALIGEN

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL VITAMIN D TESTING SALES MARKET, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL VITAMIN D TESTING SALES MARKET FOR VITAMIN D2, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL VITAMIN D TESTING SALES MARKET FOR VITAMIN D3, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL VITAMIN D TESTING SALES MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL VITAMIN D TESTING SALES MARKET FOR FUNCTIONAL FOOD AND BEVERAGES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL VITAMIN D TESTING SALES MARKET FOR PHARMACEUTICALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL VITAMIN D TESTING SALES MARKET FOR ANIMAL FEED AND PET FOOD, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL VITAMIN D TESTING SALES MARKET FOR PERSONAL CARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL VITAMIN D TESTING SALES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL VITAMIN D TESTING SALES MARKET FOR PEDIATRICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL VITAMIN D TESTING SALES MARKET FOR ADULTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL VITAMIN D TESTING SALES MARKET FOR GERIATRICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL VITAMIN D TESTING SALES MARKET FOR PREGNANT WOMEN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL VITAMIN D TESTING SALES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA VITAMIN D TESTING SALES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. U.S. VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. U.S. VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. CANADA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 23. CANADA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. CANADA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE VITAMIN D TESTING SALES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. ITALY VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 39. ITALY VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. ITALY VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. UK VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 45. UK VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. UK VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC VITAMIN D TESTING SALES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. CHINA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 58. CHINA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. CHINA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. INDIA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 64. INDIA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. INDIA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA VITAMIN D TESTING SALES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 97. UAE VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 98. UAE VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. UAE VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA VITAMIN D TESTING SALES, BY VITAMIN TYPE, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA VITAMIN D TESTING SALES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA VITAMIN D TESTING SALES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 106. BIOMRIEUX INC: KEY EXECUTIVES
  • TABLE 107. BIOMRIEUX INC: COMPANY SNAPSHOT
  • TABLE 108. BIOMRIEUX INC: OPERATING SEGMENTS
  • TABLE 109. BIOMRIEUX INC: PRODUCT PORTFOLIO
  • TABLE 110. BIOMRIEUX INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. ABBOTT LABORATORIES INC.: KEY EXECUTIVES
  • TABLE 112. ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT
  • TABLE 113. ABBOTT LABORATORIES INC.: OPERATING SEGMENTS
  • TABLE 114. ABBOTT LABORATORIES INC.: PRODUCT PORTFOLIO
  • TABLE 115. ABBOTT LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. SIEMENS HEALTHINEERS: KEY EXECUTIVES
  • TABLE 117. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
  • TABLE 118. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
  • TABLE 119. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
  • TABLE 120. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. F. HOFFMANN-LA ROCHE: KEY EXECUTIVES
  • TABLE 122. F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT
  • TABLE 123. F. HOFFMANN-LA ROCHE: OPERATING SEGMENTS
  • TABLE 124. F. HOFFMANN-LA ROCHE: PRODUCT PORTFOLIO
  • TABLE 125. F. HOFFMANN-LA ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. DIASORIN S.P.A.: KEY EXECUTIVES
  • TABLE 127. DIASORIN S.P.A.: COMPANY SNAPSHOT
  • TABLE 128. DIASORIN S.P.A.: OPERATING SEGMENTS
  • TABLE 129. DIASORIN S.P.A.: PRODUCT PORTFOLIO
  • TABLE 130. DIASORIN S.P.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 131. HOLOGIC, INC.: KEY EXECUTIVES
  • TABLE 132. HOLOGIC, INC.: COMPANY SNAPSHOT
  • TABLE 133. HOLOGIC, INC.: OPERATING SEGMENTS
  • TABLE 134. HOLOGIC, INC.: PRODUCT PORTFOLIO
  • TABLE 135. HOLOGIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 136. BIOKIT S.A.: KEY EXECUTIVES
  • TABLE 137. BIOKIT S.A.: COMPANY SNAPSHOT
  • TABLE 138. BIOKIT S.A.: OPERATING SEGMENTS
  • TABLE 139. BIOKIT S.A.: PRODUCT PORTFOLIO
  • TABLE 140. BIOKIT S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 141. THE VITAMIN D COMPANY: KEY EXECUTIVES
  • TABLE 142. THE VITAMIN D COMPANY: COMPANY SNAPSHOT
  • TABLE 143. THE VITAMIN D COMPANY: OPERATING SEGMENTS
  • TABLE 144. THE VITAMIN D COMPANY: PRODUCT PORTFOLIO
  • TABLE 145. THE VITAMIN D COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. TOSOH BIOSCIENCE: KEY EXECUTIVES
  • TABLE 147. TOSOH BIOSCIENCE: COMPANY SNAPSHOT
  • TABLE 148. TOSOH BIOSCIENCE: OPERATING SEGMENTS
  • TABLE 149. TOSOH BIOSCIENCE: PRODUCT PORTFOLIO
  • TABLE 150. TOSOH BIOSCIENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. QUALIGEN: KEY EXECUTIVES
  • TABLE 152. QUALIGEN: COMPANY SNAPSHOT
  • TABLE 153. QUALIGEN: OPERATING SEGMENTS
  • TABLE 154. QUALIGEN: PRODUCT PORTFOLIO
  • TABLE 155. QUALIGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL VITAMIN D TESTING SALES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL VITAMIN D TESTING SALES MARKET
  • FIGURE 3. SEGMENTATION VITAMIN D TESTING SALES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN VITAMIN D TESTING SALES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVITAMIN D TESTING SALES MARKET
  • FIGURE 11. VITAMIN D TESTING SALES MARKET SEGMENTATION, BY BY VITAMIN TYPE
  • FIGURE 12. VITAMIN D TESTING SALES MARKET FOR VITAMIN D2, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. VITAMIN D TESTING SALES MARKET FOR VITAMIN D3, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. VITAMIN D TESTING SALES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. VITAMIN D TESTING SALES MARKET FOR FUNCTIONAL FOOD AND BEVERAGES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. VITAMIN D TESTING SALES MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. VITAMIN D TESTING SALES MARKET FOR ANIMAL FEED AND PET FOOD, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. VITAMIN D TESTING SALES MARKET FOR PERSONAL CARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. VITAMIN D TESTING SALES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 20. VITAMIN D TESTING SALES MARKET FOR PEDIATRICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. VITAMIN D TESTING SALES MARKET FOR ADULTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. VITAMIN D TESTING SALES MARKET FOR GERIATRICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. VITAMIN D TESTING SALES MARKET FOR PREGNANT WOMEN, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 28. COMPETITIVE DASHBOARD
  • FIGURE 29. COMPETITIVE HEATMAP: VITAMIN D TESTING SALES MARKET
  • FIGURE 30. TOP PLAYER POSITIONING, 2024
  • FIGURE 31. BIOMRIEUX INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. BIOMRIEUX INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. BIOMRIEUX INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. ABBOTT LABORATORIES INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. ABBOTT LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. ABBOTT LABORATORIES INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. SIEMENS HEALTHINEERS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. SIEMENS HEALTHINEERS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. F. HOFFMANN-LA ROCHE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. F. HOFFMANN-LA ROCHE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. F. HOFFMANN-LA ROCHE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. DIASORIN S.P.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. DIASORIN S.P.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. DIASORIN S.P.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. HOLOGIC, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. HOLOGIC, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. HOLOGIC, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. BIOKIT S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. BIOKIT S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. BIOKIT S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. THE VITAMIN D COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. THE VITAMIN D COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. THE VITAMIN D COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. TOSOH BIOSCIENCE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. TOSOH BIOSCIENCE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. TOSOH BIOSCIENCE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. QUALIGEN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. QUALIGEN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. QUALIGEN: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Vitamin D Testing Sales Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved